Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Insightful1on Jul 29, 2021 2:33pm
149 Views
Post# 33626570

RE:RE:RE:RE:RE:CEO

RE:RE:RE:RE:RE:CEOMedX's technology is fully secure from a number of positions. Firstly, the patents protect the IP however people can work around patents and spectrophotometry is a well known science. Where MedX is protected is the SIAscope is a Class 2 medical device which require a very long and expensive regulatory process to gain clearance to sell in any country. MedX can sell in 38 countries.  It takes approximately 1 year to pass the regulatory standards before you are able to sell a similar product in the market. Then you have to design and develop a teledermatology,secure platform in order to move and store the patient's images and private health information.  The patient's information will need to be secured in the country of origin and if you want it to be scalable you will require SOC1 level security. This will take a year and a half to design and build. there are numerous additional capabilities you will require in order to be considered a true medical device in the dermatology space. So I think MedX is well protected in this space. Hope this helps.
<< Previous
Bullboard Posts
Next >>